Organon (OGN) Tops Q3 EPS by 15c; Narrows Outlook

Organon (NYSE: OGN) reported Q3 EPS of $1.32, $0.15 better than the analyst estimate of $1.17. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.53 billion.

GUIDANCE:

Organon sees FY2022 revenue of $6.1-6.2 billion, versus the consensus of $6.17 billion. Adjusted EBITDA margin range narrowed and raised to 33.5% to 34.5%.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• C.H. Robinson acquires DeSpir Logistics for $75 million
• MP Materials seen largely insulated after China export-control move